Medical devices, healthcare technology and the business of care
PMA approval · P170013

Low-Profile Visualized Intraluminal Support (LVIS) and LVIS Jr.

Microvention, Inc. · Decision date May 30, 2018

MEDTECHLEDGER EXPLANATIONP170013

What did the FDA approve?

FDA approved PMA P170013 for the Low-Profile Visualized Intraluminal Support (LVIS) and LVIS Jr. from MicroVention, Inc. The approval statement describes the device as indicated for use with neurovascular embolization coils in patients 18 years or older for wide-neck saccular intracranial aneurysms, defined as neck width of 4 mm or greater or dome-to-neck ratio below 2, arising from a parent vessel with diameter between 2.0 mm and 4.5 mm.

The decision date is May 30, 2018, and the product code is QCA under the specialty of Neurology. The record does not include a supplement type or supplement reason, so no changed item or relationship to an earlier PMA is stated. The approval statement reports the device's indicated use but does not itself provide independent proof of safety or clinical effectiveness.

FDA approval order statement

Approval for the Low-Profile Visualized Intraluminal Support (LVIS) and LVIS Jr. This device is indicated for use with neurovascular embolization coils in patients >= 18 years of age for the treatment of wide-neck (neck width >= 4 mm or dome to neck ratio < 2) saccular intracranial aneurysms arising from a parent vessel with a diameter >= 2.0 mm and <= 4.5 mm.
Regulatory pathway
Original PMA
Clinical specialty
Neurology
Decision date
May 30, 2018

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P170013
Regulatory pathway
Premarket approval application
Product code
QCA
Decision code
APPR
Decision date
May 30, 2018
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Intracranial coil-assist stent.

Product code
QCA
FDA device class
3

The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.

FDA decision timeline

  1. P170013 received

    Application receipt date recorded by FDA.

  2. P170013 · FDA decision

    APPR

  3. P170013/S013 · Related supplement

    Intraluminal Support Device LVIS/LVIS Jr./LVIS EVO

Timeline entries are records held by MedtechLedger for P170013. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P170013

Product / regulatory recordCompanyPathwayDecision dateSource
Microvention, Inc.PMA supplementSep 16, 2026FDA

Explore the linked device profile

Other records with product code QCA

Product / regulatory recordCompanyPathwayDecision dateSource
Stryker NeurovascularPMA supplementOct 24, 2026FDA
Stryker NeurovascularPMA approvalMay 16, 2019FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Microvention, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
35 Enterprise, Aliso Viejo, CA, 92656

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records